Reverse translation of adverse event reports paves the way for de-risking preclinical off-targets.
Ontology highlight
ABSTRACT: The Food and Drug Administration Adverse Event Reporting System (FAERS) remains the primary source for post-marketing pharmacovigilance. The system is largely un-curated, unstandardized, and lacks a method for linking drugs to the chemical structures of their active ingredients, increasing noise and artefactual trends. To address these problems, we mapped drugs to their ingredients and used natural language processing to classify and correlate drug events. Our analysis exposed key idiosyncrasies in FAERS, for example reports of thalidomide causing a deadly ADR when used against myeloma, a likely result of the disease itself; multiplications of the same report, unjustifiably increasing its importance; correlation of reported ADRs with public events, regulatory announcements, and with public
SUBMITTER: Maciejewski M
PROVIDER: S-EPMC5548487 | biostudies-literature | 2017 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA